Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.

Wolffenbuttel, B H; Sels, J P; Rondas-Colbers, G J; Menheere, P P

Wolffenbuttel, B H; Sels, J P; Rondas-Colbers, G J; Menheere, P P.

Affiliation

Wolffenbuttel BH; Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. bwo@sint.azm.nl

Neth J Med ; 54(2): 63-9, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10079680

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Hypoglycemic Agents/therapeutic use; Insulin/therapeutic use; Aged; Biomarkers/blood; Blood Glucose/metabolism; Body Mass Index; Diabetes Mellitus, Type 2/blood; Drug Therapy, Combination; Female; Follow-Up Studies; Glyburide/therapeutic use; Glycated Hemoglobin/metabolism; Humans; Insulin/blood; Insulin Resistance/physiology; Male; Prognosis; Prospective Studies

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Insulin Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Year: 1999 Type: Article

Search on Google

XML

PubMed Links